These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 30787053)
1. Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non-Small Cell Lung Cancer Patients. Palazzo LL; Sheehan DF; Tramontano AC; Kong CY Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):926-934. PubMed ID: 30787053 [TBL] [Abstract][Full Text] [Related]
2. EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky. Larson KL; Huang B; Chen Q; Tucker T; Schuh M; Arnold SM; Kolesar JM PLoS One; 2020; 15(8):e0237790. PubMed ID: 32810185 [TBL] [Abstract][Full Text] [Related]
3. Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States. Enewold L; Thomas A PLoS One; 2016; 11(6):e0156728. PubMed ID: 27294665 [TBL] [Abstract][Full Text] [Related]
4. Race and sex differences in the receipt of timely and appropriate lung cancer treatment. Shugarman LR; Mack K; Sorbero ME; Tian H; Jain AK; Ashwood JS; Asch SM Med Care; 2009 Jul; 47(7):774-81. PubMed ID: 19536007 [TBL] [Abstract][Full Text] [Related]
5. Racial Disparities in Resection of Early Stage Non-Small Cell Lung Cancer: Variability Among Surgeons. Ezer N; Mhango G; Bagiella E; Goodman E; Flores R; Wisnivesky JP Med Care; 2020 Apr; 58(4):392-398. PubMed ID: 31895307 [TBL] [Abstract][Full Text] [Related]
6. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations. Williams CD; Alpert N; Redding TS; Bullard AJ; Flores RM; Kelley MJ; Taioli E Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):112-118. PubMed ID: 31624076 [TBL] [Abstract][Full Text] [Related]
7. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Hardy D; Liu CC; Xia R; Cormier JN; Chan W; White A; Burau K; Du XL Cancer; 2009 May; 115(10):2199-211. PubMed ID: 19365824 [TBL] [Abstract][Full Text] [Related]
8. Persistence of racial disparities in early-stage lung cancer treatment. Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165 [TBL] [Abstract][Full Text] [Related]
9. Racial differences in the treatment of early-stage lung cancer. Bach PB; Cramer LD; Warren JL; Begg CB N Engl J Med; 1999 Oct; 341(16):1198-205. PubMed ID: 10519898 [TBL] [Abstract][Full Text] [Related]
10. Racial and socioeconomic disparities in survival among patients with metastatic non-small cell lung cancer. Uprety D; Seaton R; Hadid T; Mamdani H; Sukari A; Ruterbusch JJ; Schwartz AG J Natl Cancer Inst; 2024 Oct; 116(10):1697-1704. PubMed ID: 38830035 [TBL] [Abstract][Full Text] [Related]
11. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States. Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025 [No Abstract] [Full Text] [Related]
12. Urban/rural patterns in receipt of treatment for non-small cell lung cancer among black and white Medicare beneficiaries, 2000-2003. Steele CB; Pisu M; Richardson LC J Natl Med Assoc; 2011 Aug; 103(8):711-8. PubMed ID: 22046848 [TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer treatment receipt and survival among African-Americans and whites in a rural area. Hua X; Ward KC; Gillespie TW; Lipscomb J; Goodman M J Community Health; 2014 Aug; 39(4):696-705. PubMed ID: 24346819 [TBL] [Abstract][Full Text] [Related]
14. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance. Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364 [TBL] [Abstract][Full Text] [Related]
15. Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung Cancer. Shen C; Kehl KL; Zhao B; Simon GR; Zhou S; Giordano SH Clin Lung Cancer; 2017 Jul; 18(4):e233-e241. PubMed ID: 28024927 [TBL] [Abstract][Full Text] [Related]
16. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study. Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586 [TBL] [Abstract][Full Text] [Related]
17. Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. Bradley CJ; Dahman B; Given CW J Clin Oncol; 2008 Nov; 26(31):5067-73. PubMed ID: 18794546 [TBL] [Abstract][Full Text] [Related]
18. Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Esnaola NF; Gebregziabher M; Knott K; Finney C; Silvestri GA; Reed CE; Ford ME Ann Thorac Surg; 2008 Jul; 86(1):220-6; discussion 227. PubMed ID: 18573427 [TBL] [Abstract][Full Text] [Related]
19. Impact of referral patterns on the use of chemotherapy for lung cancer. Earle CC; Neumann PJ; Gelber RD; Weinstein MC; Weeks JC J Clin Oncol; 2002 Apr; 20(7):1786-92. PubMed ID: 11919235 [TBL] [Abstract][Full Text] [Related]